Pharmakon
Pharmaceuticals, Inc. is voluntarily recalling all lots of sterile products aseptically compounded
and packaged by Pharmakon Pharmaceuticals, Inc. that remain within expiry due to
the FDA’s concern over a lack of sterility assurance and other quality
issues.
Administration of a sterile drug product intended to be sterile that is compromised may result in serious and potentially life-threatening infections or death. To date, Pharmakon Pharmaceuticals, Inc. has not received any reports of adverse effects or injuries.
These compounded sterile products are used for a variety of indications and are packaged in bags, syringes, and cad cassettes. All recalled products have a label that includes the Pharmakon Pharmaceuticals, Inc. name, address, and expiration date. The sterile products were distributed nationwide to hospitals between March 4, 2016 and April 15, 2016.
Pharmakon Pharmaceuticals, Inc. is notifying its customers that received sterile compounded products via email and is arranging for return of all recalled products.
Posted by Dr. Tim Sandle
Administration of a sterile drug product intended to be sterile that is compromised may result in serious and potentially life-threatening infections or death. To date, Pharmakon Pharmaceuticals, Inc. has not received any reports of adverse effects or injuries.
These compounded sterile products are used for a variety of indications and are packaged in bags, syringes, and cad cassettes. All recalled products have a label that includes the Pharmakon Pharmaceuticals, Inc. name, address, and expiration date. The sterile products were distributed nationwide to hospitals between March 4, 2016 and April 15, 2016.
Pharmakon Pharmaceuticals, Inc. is notifying its customers that received sterile compounded products via email and is arranging for return of all recalled products.
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources